GENE ONLINE|News &
Opinion
Blog

Feature
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
SK Life Science Steps Forward in Treating Seizure Disorders
2022-01-13
JPM22 Highlights: Innovative Partnerships to Reimagine Personalized Care
At the annual J.P.Morgan Healthcare Conference, which began on January 10, 2022, industry experts look into the big trends, emerging companies and innovative technologies which will shape biotech and healthcare in 2022. Illumina and J&J announced their new partnerships to drive innovation in the healthcare sector in 2022. 
2022-01-11
With A New Medical Device and Accompanying Platform, Roche Advances its Digital Ecosystem
2022-01-14
Special
Biotech Showcase 2022: Healing the Psyche with Psychedelia
The Biotech Showcase 2022 began on January 10th and prominently featured a panel on the use of psychedelics in the treatment of psychological and central nervous system (CNS) disorders. Moderated by Walter Greenleaf; the four panelists discussed the use of MDMA, Psilocybin and LSD for a variety of disorders and  the obstacles involved in the endeavor.
2022-01-17
Recent Advances in Breast Cancer Treatments: An Overview
Breast cancer has the second high prevalence among all types of cancer in the US. The average risk of a woman developing it and dying from the disease stands at 13% and 2.6%, making it the second leading cause of cancer death in women.

Breast cancer subtypes are defined by their histopathological appearance and expression of hormone receptors (HR) and growth factors, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).

Recent advances in breast cancer treatments provide more approaches to improve the progression-free survival and overall survival rates in patients; developing new agents and strategies can improve drug resistance and efficacy in current treatment. Breast cancer treatments are majorly decided by the cancer stage, subtype, patient's overall health, menopause status, and cancer growth rate.

2022-01-15
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
Two deals punctuate the second day of J.P. Morgan’s healthcare conference 2022. They include Amgen tapping Arrakis to hunt for a new class of drugs that target RNA and Roche investing once again in multiomics player Freenome to help them realize their early cancer detection goals.  
2022-01-12
LATEST
Biotech Showcase 2022: Healing the Psyche with Psychedelia
2022-01-17
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
Study Reveals a Form of Four-Stranded DNA that Links Protein Deficiency and Premature Aging
2022-01-17
Shanghai’s Everest Medicines Licenses Covid-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
Deals
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
Freenome Raises $300 Million Series D for Cancer-Detecting Multiomics Platform
2021-12-08
Vertex Is Looking to Become Singapore’s First SPAC
2022-01-10
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
GeneOnline’s Top 10 M&As of 2021
2022-01-11
Quidel to Acquire Ortho Clinical for $6 billion to Diversify Diagnostics Portfolio
2021-12-24
Novartis Books Gyroscope for $1.5 Billion in Pursuit of Gene Therapy for Blindness
2021-12-23
Ranking & Reports
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
9 Leading Molecular Diagnostics Companies to Watch in Taiwan
2021-11-15
The 8 Companies Propelling Taiwan’s Biopharma Industry
2021-10-21
Categories
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
Can Regulations Measure up to the Progress of Precision Medicine in Taiwan? – An Interview With Dr. Johnsee Lee
2021-10-30
How Can Taiwan’s Biopharma Seize the Next Global Business Opportunity? – An Interview with Dr. Jerome Shen
2021-10-17
Concerns Remain as Kintor Pharma’s Proxalutamide Shows Unbelievably High Efficacy Against Covid-19 Infections in Phase 3 Trials
2022-01-16
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
SK Life Science Steps Forward in Treating Seizure Disorders
2022-01-13
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
FDA Gives Emergency Approval to Merck’s Covid-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
Shanghai’s Everest Medicines Licenses Covid-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
China’s Hansoh Teams Up with Middle East Onco-Collaborator
2022-01-02
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
What are Investors Looking for in a Biotech Startup?
2021-07-27
Primed to Surpass CRISPR: Prime Medicine Emerges Out of Stealth with $315 Million in Funding
2021-07-15
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Takeda Collaborates with Immusoft to Advance Treatments in Rare Metabolic Diseases
2022-01-14
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
Grand Pharma Inks $590+ Million Deal for China Rights to ITM’s Precision Radiopharmaceuticals
2021-12-28
Gannex Pharma Announces New Dual Targeting Drug for NASH
2022-01-05
AstraZeneca, Ionis Close $3.5+ Billion Deal for Rare Protein Misfolding Disorder
2021-12-30
Harnessing the potential of CRISPR-Cas9 for Gut Microbiome Gene Editing
2021-11-29
Celltrion’s New Antibody Is Effective against the Omicron Variant
2022-01-06
Scientists to Study the Effect of Microgravity on Human Brain Cells in Space
2022-01-04
A Digital Solution Tracks Pill Adherence with 98% Accuracy
2021-12-13
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!